Related Experiment Videos

Streptococcal toxic shock syndrome in children

D Floret1, D Stamm, P Cochat

  • 1Unité de Réanimation Pédiatrique, Hopital Edouard Herriot, Lyon, France.

Intensive Care Medicine
|January 1, 1992
PubMed

Insights

Two children developed toxic shock-like syndrome from Streptococcus pyogenes infections. Strains producing erythrogenic toxin B, not A, were implicated, suggesting regional differences in toxin involvement.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Toxicology

Background:

  • Toxic shock-like syndrome (TSLS) is a severe condition often associated with bacterial toxins.
  • Group A Streptococcus (GAS) is a known pathogen capable of causing TSLS.
  • Erythrogenic toxins (ETs) produced by GAS are implicated in the pathogenesis of TSLS.

Observation:

  • Two pediatric cases of TSLS secondary to soft tissue streptococcal infections are presented.
  • One of the two cases was fatal.
  • Blood cultures identified Streptococcus pyogenes in both children.

Findings:

  • The isolated Streptococcus pyogenes strains produced significant quantities of erythrogenic toxin B (ET B) and smaller amounts of ET C.
  • Notably, these strains did not produce erythrogenic toxin A (ET A).
  • This contrasts with many reported US cases where ET A is considered the primary toxin.

Implications:

  • This study reinforces the role of Streptococcus pyogenes in TSLS.
  • The findings suggest that strains producing high levels of ET B may be more prevalent in TSLS cases observed in Europe.
  • Understanding regional variations in ET production is crucial for accurate diagnosis and treatment of streptococcal TSLS.

Related Concept Videos